Sign Up Today and Learn More About MedGenome Stock
Invest in or calculate the value of your shares in MedGenome or other pre-IPO companies through EquityZen's platform.
MedGenome Stock
MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.
About MedGenome Stock
Founded
2013
Industries
Software, Artificial Intelligence, Data and Analytics
MedGenome Press Mentions
Stay in the know about the latest news on MedGenome
Reliance eyes Jio-style disruption in genomics with sub-Rs 1,000 tests
economictimes • Dec 17, 2025
Servier India Partners With MedGenome, Strand Life Sciences on Cancer Biomarker Testing
genomeweb • Nov 14, 2025
Servier India partners with two genomic laboratories to advance specific type of cancer testing
thehindubusinessline • Nov 11, 2025
Servier India launches subsidised biomarker tests for rare cancers
business-standard • Nov 11, 2025
Novo Holdings in talks to buy into Surya Hospitals
economictimes • Sep 16, 2025
MedGenome Management
Leadership team at MedGenome
Chief Executive Officer (India)
Vedam Ramprasad
CFO
Surajit Chakrabartty
Join now and verify your accreditation status to gain access to:
- MedGenome Current Valuation
- MedGenome Stock Price
- MedGenome Management
- Available deals in MedGenome and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- MedGenome Cap Table and Funding History by Share Class and Liquidity Preferences
- MedGenome Revenue and Financials
- MedGenome Highlights
- MedGenome Business Model
- MedGenome Risk Factors
- MedGenome Research Report from SACRA Research
Trading MedGenome Stock
How to invest in MedGenome stock?
Accredited investors can buy pre-IPO stock in companies like MedGenome through EquityZen funds. These investments are made available by existing MedGenome shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell MedGenome stock?
Shareholders can sell their MedGenome stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."